Smiths Medical 21-4035-24 - PORT INFUSION SINGLE LUMEN TITANIUM DETACHED SILICONE CATHETER 9FR INTRODUCER LOW PROFILE

Smiths Medical 21-4035-24 - PORT INFUSION SINGLE LUMEN TITANIUM DETACHED SILICONE CATHETER 9FR INTRODUCER LOW PROFILE

The Smiths Medical 21-4035-24 infusion port is a single lumen, low-profile implantable device designed for reliable long-term vascular access. Constructed with a durable titanium body and paired with a detached silicone catheter, this system supports consistent performance in demanding clinical environments. The 9FR catheter size and included introducer enable efficient placement while minimizing patient discomfort. Its low-profile design enhances patient comfort and reduces visibility under the skin, making it suitable for extended therapies such as chemotherapy, parenteral nutrition, and repeated medication administration.

Key Benefits

This infusion port offers a robust titanium housing that ensures long-term durability and resistance to corrosion. The single lumen configuration provides dependable access for routine infusion therapies while maintaining a simple, efficient design. The detached silicone catheter enhances flexibility and reduces the risk of vessel irritation. Its low-profile structure improves patient comfort and aesthetic outcomes, while the included introducer facilitates smooth and controlled insertion. The system is engineered for consistent flow performance and ease of access during repeated use.

Compatibility and Applications

The device is compatible with standard non-coring Huber needles and is suitable for a wide range of infusion therapies. It is commonly used in oncology settings for chemotherapy delivery, as well as for long-term antibiotic therapy, parenteral nutrition, and frequent blood sampling. The system integrates seamlessly into hospital, outpatient, and specialty care environments where reliable vascular access is essential.

Usage Guidelines

The port should be implanted by a qualified healthcare professional using sterile technique. Proper placement must be confirmed prior to use. Access should always be performed using a compatible non-coring needle to maintain septum integrity. Routine flushing protocols should be followed to prevent occlusion, and the site should be regularly monitored for signs of infection or complications. Only trained clinicians should handle insertion, access, and maintenance procedures.

Certifications and Safety Standards

This infusion port is manufactured in compliance with recognized medical device quality standards. It is produced under strict quality control processes to ensure safety, sterility, and consistent performance. Materials used in the device are biocompatible and suitable for long-term implantation, meeting established healthcare regulatory requirements.

Comparison with Competitors

Compared to standard plastic or composite ports, the titanium construction provides enhanced strength and longevity. The detached silicone catheter offers improved flexibility over integrated catheter systems, reducing stress on the vessel wall. Its low-profile design distinguishes it from bulkier alternatives, offering better patient comfort and cosmetic outcomes. The inclusion of an introducer also simplifies placement compared to systems requiring separate components.

Typical User Profile and Application Scenarios

This product is ideal for oncologists, interventional radiologists, and vascular access specialists managing patients who require long-term or repeated infusion therapy. It is commonly used in cancer treatment centers, infusion clinics, and hospitals where consistent vascular access is critical. Patients undergoing chemotherapy, long-term IV therapy, or nutritional support benefit significantly from this system.

Best Practices for Use and Maintenance

To ensure optimal performance, the port should be flushed regularly according to institutional protocols. Only appropriate non-coring needles should be used to access the septum. The insertion site should be inspected routinely for any signs of infection or irritation. Proper training in port access and maintenance is essential to extend device life and maintain patient safety. Adhering to aseptic techniques during every access minimizes complication risks.

Regulatory and Safety Information

This device is intended for use by trained healthcare professionals only. It is designed for long-term implantation and must be handled in accordance with clinical guidelines and institutional policies. Any adverse events or complications should be reported and managed promptly. The product is supplied sterile and should not be used if packaging integrity is compromised.

How to Order

To place an order or to speak with a product specialist, please contact CIA Medical at (312) 275-5850. Our team is available to assist with product selection, bulk pricing, and delivery options to meet your facilitys needs.